Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|August 7, 2012
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trialWolfgang U Knauf, Toshko Lissitchkov, Ali Aldaoud, et al.
Clinical Drug Investigation|March 29, 2008
Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week OffM B Regazzi, D Russo, I Iacona, et al.
American Journal of Hematology|February 25, 2016
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA studyFrancesco Zaja, Wilma Barcellini, Silvia Cantoni, et al.
Blood|May 29, 2008
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trialAntonio Palumbo, Sara Bringhen, Anna M Liberati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) studyA Levis, A P Anselmo, A Ambrosetti, et al.
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
British Journal of Haematology|May 10, 2017
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myelomaShaji Kumar, Philippe Moreau, Parameswaran Hari, et al.
Hematological Oncology|May 20, 2017
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana LinfomiStefano Luminari, Elda Viel, Andrés José Maria Ferreri, et al.
Leukemia & Lymphoma|November 25, 2016
Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trialFrancesca R Mauro, Angelo M Carella, Stefano Molica, et al.
Bone Marrow Transplantation|February 3, 2015
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantationA Brioli, G Perrone, F Patriarca, et al.
Pageof 21